SCHEMBL5070846

SCHEMBL5070846

Cc1ccccc1-c1c(C(=O)O)ccc2ccccc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 1/20 0.71
LDHA P00338 1/20 0.54
SOS1 Q07889 2/20 0.54
ALDH1A1 P00352 2/20 0.54
KDM4E B2RXH2 1/20 0.54
HPGD P15428 1/20 0.54
MYC P01106 1/20 0.53
NR4A1 P22736 1/20 0.50
NR4A2 P43354 1/20 0.50
NR4A3 Q92570 1/20 0.50
MCL1 Q07820 3/20 0.46
CSNK2A2 P19784 1/20 0.45
CSNK2B P67870 1/20 0.45
CSNK2A1 P68400 1/20 0.45
CDC25B P30305 1/20 0.45
BAD Q92934 1/20 0.44
ACMSD Q8TDX5 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14225351 0.85 WDR5 (0.79) WDR5LDHASOS1ALDH1A1KDM4E
SCHEMBL14150504 0.84 WDR5 (0.63) WDR5LDHASOS1ALDH1A1KDM4E
SCHEMBL29458346 0.84 WDR5 (0.79) WDR5LDHASOS1ALDH1A1KDM4E
SCHEMBL9124028 0.84 WDR5 (0.79) WDR5LDHASOS1ALDH1A1KDM4E
SCHEMBL895573 0.84 WDR5 (1.00) WDR5LDHASOS1ALDH1A1KDM4E
SCHEMBL29721418 0.84 WDR5 (1.00) WDR5LDHASOS1ALDH1A1KDM4E
SCHEMBL14052430 0.83 KEAP1 (0.48) WDR5LDHASOS1ALDH1A1KDM4E
SCHEMBL28044056 0.82 MYC (0.65) WDR5LDHASOS1ALDH1A1KDM4E
SCHEMBL14397431 0.82 WDR5 (0.69) WDR5LDHASOS1ALDH1A1KDM4E
SCHEMBL10789310 0.80 MYC (0.72) ALDH1A1KDM4EHPGDMYCMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1561743-B1 COMPOUND PROTECTING AGAINST ULTRAVIOLET LEAD CHEM CO LTD (JP) 2017-01-04 EP disclosed
US-20120316337-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP UNIVERSITE DU MAINE (FR) 2012-12-13 US disclosed
US-20120316337-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP UNIVERSITE DU MAINE (FR) 2012-12-13 US disclosed
US-20120316337-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP UNIVERSITE DU MAINE (FR) 2012-12-13 US disclosed
CN-101175720-A Novel haloalkyl sulfone substituted compounds useful for the treatment of obesity and diabetes NOVO NORDISK AS (DK) 2008-05-07 CN disclosed
US-7361785-B2 Compound protecting against ultraviolet rays LEAD CHEMICAL CO., LTD. (JP) 2008-04-22 US disclosed
US-20060051303-A1 Compound protecting against ultraviolet LEAD CHEMICAL CO., LTD. (JP) 2006-03-09 US disclosed
EP-1561743-A1 COMPOUND PROTECTING AGAINST ULTRAVIOLET Lead Chemical Co. Ltd. (JP) 2005-08-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120316337-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP COMT, NAA15, NUDC WDR5 3436/4885LDHA 2726/4885SOS1 2715/4885
US-20060051303-A1 Compound protecting against ultraviolet ERCC4, ERCC2, XPA WDR5 850/4885LDHA 4727/4885SOS1 2224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.